CGt
Yep
They went from a comparable market cap 4.70 to BTA to 1.64 nearly overnight when the news came about perimivir.
If it was this time last year then I reckon BTA would of used BCRX as their Nasdaq entry with less heartache than NABI.
It would of been a good scientific mix.
Oh well. NABI we got. Shame
Add to My Watchlist
What is My Watchlist?